These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 9699506

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
    Owens JM, Fuller K, Chambers TJ.
    J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Calcitonin-like effects of forskolin and choleratoxin on surface area and motility of isolated rabbit osteoclasts.
    Ransjö M, Lerner UH, Heersche JN.
    J Bone Miner Res; 1988 Dec; 3(6):611-9. PubMed ID: 3251398
    [Abstract] [Full Text] [Related]

  • 26. The majority of osteoclasts require mRNA and protein synthesis for bone resorption in vitro.
    Hall TJ, Schaeublin M, Chambers TJ.
    Biochem Biophys Res Commun; 1993 Sep 30; 195(3):1245-53. PubMed ID: 8216256
    [Abstract] [Full Text] [Related]

  • 27. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R, Kamel S, Wattel A, Prouillet C, Sevenet N, Petit JP, Tordjmann T, Brazier M.
    J Cell Biochem; 2003 Apr 15; 88(6):1145-56. PubMed ID: 12647297
    [Abstract] [Full Text] [Related]

  • 28. Regulation of osteoclasts by calcitonin and amphiphilic calcitonin conjugates: role of cytosolic calcium.
    Komarova SV, Shum JB, Paige LA, Sims SM, Dixon SJ.
    Calcif Tissue Int; 2003 Sep 15; 73(3):265-73. PubMed ID: 14667140
    [Abstract] [Full Text] [Related]

  • 29. [The molecular mechanism of osteoclastic bone resorption and inhibitory drugs for bone resorption].
    Yamamoto Y, Noguchi T, Udagawa N.
    Clin Calcium; 2005 Jul 15; 15(7):11-6. PubMed ID: 15995290
    [Abstract] [Full Text] [Related]

  • 30. Functional consequences of the interaction of Ni2+ with the osteoclast Ca2+ 'receptor'.
    Bax BE, Shankar VS, Bax CM, Alam AS, Zara S, Moonga BS, Pazianas M, Huang CL, Zaidi M.
    Exp Physiol; 1993 Jul 15; 78(4):517-29. PubMed ID: 8398105
    [Abstract] [Full Text] [Related]

  • 31. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
    Alam AS, Gallagher A, Shankar V, Ghatei MA, Datta HK, Huang CL, Moonga BS, Chambers TJ, Bloom SR, Zaidi M.
    Endocrinology; 1992 Jun 15; 130(6):3617-24. PubMed ID: 1597159
    [Abstract] [Full Text] [Related]

  • 32. Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin.
    Murrills RJ, Shane E, Lindsay R, Dempster DW.
    J Bone Miner Res; 1989 Apr 15; 4(2):259-68. PubMed ID: 2728929
    [Abstract] [Full Text] [Related]

  • 33. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro.
    Moonga BS, Dempster DW.
    J Bone Miner Res; 1995 Mar 15; 10(3):453-7. PubMed ID: 7785467
    [Abstract] [Full Text] [Related]

  • 34. Pulsed electromagnetic field stimulation of bone marrow cells derived from ovariectomized rats affects osteoclast formation and local factor production.
    Chang K, Hong-Shong Chang W, Yu YH, Shih C.
    Bioelectromagnetics; 2004 Feb 15; 25(2):134-41. PubMed ID: 14735564
    [Abstract] [Full Text] [Related]

  • 35. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.
    McSheehy PM, Chambers TJ.
    Endocrinology; 1986 Feb 15; 118(2):824-8. PubMed ID: 3455914
    [Abstract] [Full Text] [Related]

  • 36. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
    Wezeman FH, Kuettner KE, Horton JE.
    Anat Rec; 1979 Jul 15; 194(3):311-23. PubMed ID: 224732
    [Abstract] [Full Text] [Related]

  • 37. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
    Greenfield EM, Shaw SM, Gornik SA, Banks MA.
    J Clin Invest; 1995 Sep 15; 96(3):1238-44. PubMed ID: 7657797
    [Abstract] [Full Text] [Related]

  • 38. A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells.
    Sugawara K, Hamada M, Hosoi S, Tamaoki T.
    Anal Biochem; 1998 Jan 15; 255(2):204-10. PubMed ID: 9451505
    [Abstract] [Full Text] [Related]

  • 39. Direct stimulation of bone resorption by thyroid hormones.
    Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG.
    J Clin Invest; 1976 Sep 15; 58(3):529-34. PubMed ID: 182721
    [Abstract] [Full Text] [Related]

  • 40. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W.
    Bone; 2006 Aug 15; 39(2):325-35. PubMed ID: 16580896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.